Tuesday, September 30, 2014 7:48:38 AM
"Initially, we offered a zero down loan program that worked for some customers, but we were seeing a substantial amount of potential business left on the table because we could not match clients' cash-flow needs with system finance options. To overcome this challenge, we now offer access to a range of programs in addition to our zero down loan program such as lease-to-own, PACE and Hero property tax assessment financing, and power purchase options for non-profits," stated CEO Tom Djokovich, “The level of interest we are seeing in commercial solar systems is quite extraordinary.
In June alone we added over 1-megawatt of commercial solar system proposals to our sales pipeline totaling over $3 million, and that's just the beginning of what we see as increasing business opportunities through the expansion of our commercial systems sales force."
XsunX has identified a large opportunity for smaller commercial installation programs that larger solar companies continue to overlook simply based on the inflated overhead that they need to pay for. The potential revenue and resulting gross profit is well suited for a company like XsunX who does not have massive overhead and continues to build a strong sales pipeline to grow off of.
Read more: http://www.digitaljournal.com/pr/2216759#ixzz3EnZLjMnw
Recent XSNX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 08:06:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/27/2024 09:52:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 01:38:21 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/09/2024 05:40:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2024 01:47:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 06:44:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/18/2024 09:02:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 01:49:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 08:55:22 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 05:31:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 07:30:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2023 01:27:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 03:52:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 05:27:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 06:50:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2023 03:54:57 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM